mi ophthalmology products

BOC Instruments is now the exclusive Australian distributor for all Frey products, including slit lamps, auto perimeters, and LCD acuity charts.

Frey AP-600 (pictured) and AP600-L auto perimeters have a modern space-saving design with a built-in PC. Features include a responsive 17” capacity touch display, LED maintenance-free light source, innovative liquid lens technology, liquid lens eye tracking camera, and head sensors. Fast testing time of the Threshold Interactive Algorithm (TIA) improves practice workflow and enhances patient comfort.

Frey slit lamps include the SL100, SL110 and the newly released SLI200-4K photographic slit lamp, which boasts an impressive 4K resolution, providing an unparalleled opportunity to visualise morphology and blood flow within the eye’s vasculature.

The Frey LCD CP400 and CP600-P digital acuity charts have an abundance of features. More than 9,000 Frey charts are installed worldwide.

The Meridian MRQ SLT offers precise, non-invasive selective laser trabeculoplasty. It delivers targeted energy to the trabecular meshwork, resulting in effective intraocular pressure reduction. Its intuitive interface and integrated LED slit lamp enhance usability. A range of offset settings, touch screen controls, and reliable Swiss engineering ensure consistent outcomes and a streamlined workflow. Multiple table options provide comfort for both patients and clinicians.

The compact Merilas 810 laser complements the MRQ SLT, providing versatile transscleral cyclophotocoagulation for advanced glaucoma cases. Optional short-pulse, subthreshold treatments are available, along with efficient cooling, and adjustable parameters for controlled energy delivery.

Together, these systems empower clinicians with proven technology for early and late-stage glaucoma management.

Lumibird Medical – a world leader in lasers in ophthalmology – offers a comprehensive approach to glaucoma laser therapy, with treatment options at every stage of the disease paradigm.

Selective laser trabeculoplasty (SLT) plays a critically important role in the treatment of glaucoma. The Ellex Tango and Tango Reflex Neo laser platforms deliver a gentle yet effective glaucoma therapy. With SLT laser and powerful, precise YAG laser, the Tango and Tango Reflex Neo systems provide treatment flexibility to achieve the results you and your patients are looking for – every time.

Cobra+ is a non-mydriatic digital fundus camera for early detection of age-related macular diseases and meibomian gland disease (MGD), as well as meibomian gland atrophy.

The five-megapixel camera produces high-definition (HD) retinal images with a visual field up to 50°, even through small pupils with a diameter of 2.5 mm. Nine internal fixation points enable fast acquisition of HD peripheral retina images that can be combined into one panoramic image.

Features include automatic measurement of cup-to-disk ratios for fast glaucomatous disease detection. In combination with CSO Phoenix software and the CSO Retimax, retinal images can be overlapped with an electroretinogram multifocal test when diagnosing and following up macular degeneration and degenerative hereditary retinal diseases. On a single screen, CSO software can display multiple wavelength images from the Cobra+: original, infrared, red-free; as well as choroidal, vascular and nerve fibre images. The AVR tool measures the ratio between the branch arteriolar-venous diameter for detecting early signs of cardiovascular issues.

Developed by Glaukos, the founder of minimally invasive glaucoma surgery (MIGS), iStent infinite represents the latest evolution in the iStent family. With over one million stents implanted globally, iStent infinite is reshaping glaucoma care with refined safety, efficacy, and surgeon-centric design.

Backed by Glaukos’ ongoing commitment to MIGS innovation, iStent infinite introduces several advancements, including the capability to implant three titanium stents spanning six clock hours. This modified design significantly enhances the area of drainage coverage compared to previous models. The newly engineered system supports unlimited delivery attempts, facilitating surgical precision and efficiency.

iStent infinite is indicated for patients with open-angle glaucoma. Performed either as a standalone procedure or in conjunction with cataract surgery, it is designed to provide foundational, continuous therapy that promotes intraocular pressure control and sustained medication reduction.

iCare Compass automated tracked perimetry combines truecolor confocal fundus imaging with visual field testing in one device. Powered by Active Retinal Tracking, Compass continuously tracks eye movements and compensates in real time, ensuring accurate stimulus placement, even in patients with unstable fixation. The result is highly reliable, repeatable visual field data aligned directly with retinal anatomy. Its automated workflow, intuitive operation, and fast test times enhance efficiency in busy clinical environments, while truecolor fundus images support structure–function correlation.

iCare Compass delivers precision, consistency, and clinical confidence, helping eye care professionals make informed decisions with every test.

Miniject is iSTAR Medical’s innovative minimally invasive glaucoma surgery (MIGS) device for patients with open-angle glaucoma.

Miniject combines the distinctive porous structure of its proprietary STAR material with the power offered by the supraciliary space. It is designed to enhance physiological fluid outflow, reducing intraocular pressure (IOP) and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis, and subsequent complications.

Five-year follow-up results demonstrate sustained, meaningful, mean IOP reduction of 38% to 14.8 mmHg, with 85% of patients using the same or fewer medications. In addition, 55.3% of patients had IOP≤15 mmHg and 83% of patients achieved ≥20% IOP reduction from baseline at five-year follow up.1

Melbourne Rapid Fields (MRF) is a clinically validated, online visual field platform designed to transform glaucoma detection and monitoring. Using patented intelligent gaze control and automated screen calibration, MRF delivers fast, reliable visual field testing on standard computers (laptop/desktop/tablets) with no dedicated hardware required. This enables scalable deployment across clinics and seamless extension into the home, improving access and reducing service burden.

In a landmark 2026 publication, in collaboration with Moorfields Eye Hospital, frequent home testing with MRF (every two months or more often) was found to allow detection of glaucoma progression earlier than conventional six-monthly clinic-based visual fields.1

By enabling higher-frequency testing between visits, MRF supports earlier intervention and more patient-centred glaucoma care.

Nutravision is an award-winning eye supplement, developed specifically for those managing eye pressure, as an adjunct to standard care. It is the only formula based on the recently peer-reviewed NP 10 System,1 which identifies a targeted combination of 10 nutrients that support optic nerve and macular health, vascular function, and cellular metabolism.

Each capsule provides high-potency doses of key active ingredients, including saffron, ginkgo biloba, lutein, zeaxanthin, bilberry, vegan D3, methylcobalamin (B12), and nicotinamide (B3).

Nutravision is designed for ongoing management rather than acute treatment: a simple twice-daily capsule fits alongside prescribed drops and other therapies. Practices use it for motivated patients who ask, “What else can I do?” and want a structured, clinician-endorsed option to support long-term eye-nerve-brain health.

Eyefos optical coherence tomography (OCT), with integrated artificial intelligence, offers high-resolution images of the retina to assess structural changes, particularly in the retinal nerve fibre layer (RNFL). By enhancing diagnostic accuracy, it aids in early detection and monitoring of glaucoma disease progression. However, ultra-widefield imaging surpasses traditional methods by capturing a more extensive view of the peripheral retina, allowing for the detection of glaucomatous changes that OCT might miss. This comprehensive perspective helps in better understanding the disease’s impact and progression.

Additionally, EyeFos provides biometry services, further aiding in the assessment and management of glaucoma by measuring ocular parameters critical for effective treatment planning. Together, these technologies enhance patient care and outcomes in glaucoma management.

The Optopol Revo HR redefines glaucoma care with ultra-high 3 μm resolution and 130,000 A-scans per second for exceptional detail and early detection.

Its advanced glaucoma tool kit delivers precise analysis of the nerve fibre layer, ganglion cell layer, and optic nerve head, supported by the Disc Damage Likelihood Scale (DDLS) for accurate monitoring. Artificial intelligence (AI)-powered segmentation and real-time AccuTrack eye tracking ensure artifact-free imaging, while the structure plus function report combines optical coherence tomography and visual field data into a single, intuitive page.

Clinicians benefit from faster workflows, comprehensive progression tracking, and improved diagnostic confidence. Patients benefit from shorter, more comfortable exams, and earlier intervention for better outcomes.

Comprehensive glaucoma assessment relies on detailed evaluation of the optic nerve within the context of the wider retina. optomap ultra-widefield imaging provides practitioners with a broad, high-resolution view of the retina and optic nerve in a single, non-invasive capture. This enables subtle structural changes to be identified and documented, supporting longitudinal comparison and informed clinical assessment.

When combined with optical coherence tomography, optomap helps detect abnormalities and track disease progression over time. Fast, non-invasive, and clinically validated, it integrates seamlessly into routine workflows, supporting clinical decision-making and patient education.

With optomap, managing glaucoma becomes more precise, efficient, and patient-focused, helping preserve vision.

The Triton2 from Topcon Healthcare combines advanced swept-source optical coherence tomography (OCT) technology for high density scans with deep penetration, with a true colour fundus camera. Widefield OCT and OCT-angiography (OCT-A) deliver up to 21 mm* of view, and Smart Denoise* provides higher signal-to-noise ratio on 3D OCT and OCT-A.*

Powered by IMAGEnetÒ7, the Triton2 delivers instant clinical insights, including the Hood Report, which streamlines the decision-making process through the correlation of structure (ganglion cell layer/retinal nerve fibre layer) with function (overlay of visual field test locations).1 A single widefield OCT scan with the Hood Report can provide compelling information for the diagnosis of early glaucoma.2

By connecting devices, data, and applications, the ZEISS Cataract Workflow provides a seamless integration from the office to the operating theatre and back for cataract procedures.

In the clinic, the precise measurement and planning solutions offered by the IOL Master 700 and ATLAS 500 support enhanced clinical decision making.

ZEISS EQ Workplace is a proven digital surgery planning tool capable of creating a secure data trail across ZEISS devices. Facilitating intraocular lens (IOL) calculation and staff collaboration on a centralised interface, it makes your work more efficient and safer from transcription errors.

In the theatre, the QUATERA 700 phacoemulsification system, ARTEVO portfolio of operating microscopes, CALLISTO 5.0, and Zeiss range of premium IOLs help to deliver reliable patient outcomes, even when routine turns into a challenge.